Belotti Dorina, Pinessi Denise, Taraboletti Giulia
Laboratory of Tumor Microenvironment, Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 24126 Bergamo, Italy.
Cancers (Basel). 2021 Apr 15;13(8):1912. doi: 10.3390/cancers13081912.
Blood vessels in tumors are formed through a variety of different mechanisms, each generating vessels with peculiar structural, molecular, and functional properties. This heterogeneity has a major impact on tumor response or resistance to antineoplastic therapies and is now emerging as a promising target for strategies to prevent drug resistance and improve the distribution and efficacy of antineoplastic treatments. This review presents evidence of how different mechanisms of tumor vessel formation (vasculogenesis, glomeruloid proliferation, intussusceptive angiogenesis, vasculogenic mimicry, and vessel co-option) affect tumor responses to antiangiogenic and antineoplastic therapies, but also how therapies can promote alternative mechanisms of vessel formation, contributing to tumor recurrence, malignant progression, and acquired drug resistance. We discuss the possibility of tailoring treatment strategies to overcome vasculature-mediated drug resistance or to improve drug distribution and efficacy.
肿瘤中的血管是通过多种不同机制形成的,每种机制都会生成具有独特结构、分子和功能特性的血管。这种异质性对肿瘤对抗肿瘤治疗的反应或耐药性有重大影响,目前正成为预防耐药性以及改善抗肿瘤治疗的分布和疗效策略的一个有前景的靶点。本综述展示了不同的肿瘤血管形成机制(血管生成、肾小球样增殖、套叠式血管生成、血管生成拟态和血管共选)如何影响肿瘤对抗血管生成和抗肿瘤治疗的反应,同时也展示了这些治疗如何促进血管形成的替代机制,从而导致肿瘤复发恶性进展和获得性耐药。我们讨论了定制治疗策略以克服血管系统介导的耐药性或改善药物分布和疗效的可能性。